Divestitures in the offing as dust settles on record Johnson & Johnson buy?
This article was originally published in Clinica
Executive Summary
Although Johnson & Johnson insists there are no antitrust issues surrounding its pending purchase of Guidant, some outside experts are beginning to say otherwise.